Cargando…
Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients.
Pleural effusion samples were obtained from 55 patients with malignant disease, including patients with primary lung cancers and those with a variety of other tumours metastatic to the pleura. The effusions were assayed for the presence of hepatocyte growth factor/scatter factor (HGF/SF), by both EL...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074438/ https://www.ncbi.nlm.nih.gov/pubmed/8562345 |
_version_ | 1782137966807744512 |
---|---|
author | Eagles, G. Warn, A. Ball, R. Y. Baillie-Johnson, H. Arakaki, N. Daikuhara, Y. Warn, R. M. |
author_facet | Eagles, G. Warn, A. Ball, R. Y. Baillie-Johnson, H. Arakaki, N. Daikuhara, Y. Warn, R. M. |
author_sort | Eagles, G. |
collection | PubMed |
description | Pleural effusion samples were obtained from 55 patients with malignant disease, including patients with primary lung cancers and those with a variety of other tumours metastatic to the pleura. The effusions were assayed for the presence of hepatocyte growth factor/scatter factor (HGF/SF), by both ELISA and bioassay. The presence of malignant cells in the effusions was also assessed. Detectable amounts of the factor, as judged by both criteria, were found in over 90% of all the effusions, including those from patients with a wide variety of carcinomas and also lymphomas. A wide range of HGF/SF levels were found for all tumour classes, some effusions containing high levels above 4 ng ml-1. It is concluded that tumours within the pleura and adjacent lung tissue are usually exposed to biologically significant levels of HGF/SF. |
format | Text |
id | pubmed-2074438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1996 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20744382009-09-10 Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. Eagles, G. Warn, A. Ball, R. Y. Baillie-Johnson, H. Arakaki, N. Daikuhara, Y. Warn, R. M. Br J Cancer Research Article Pleural effusion samples were obtained from 55 patients with malignant disease, including patients with primary lung cancers and those with a variety of other tumours metastatic to the pleura. The effusions were assayed for the presence of hepatocyte growth factor/scatter factor (HGF/SF), by both ELISA and bioassay. The presence of malignant cells in the effusions was also assessed. Detectable amounts of the factor, as judged by both criteria, were found in over 90% of all the effusions, including those from patients with a wide variety of carcinomas and also lymphomas. A wide range of HGF/SF levels were found for all tumour classes, some effusions containing high levels above 4 ng ml-1. It is concluded that tumours within the pleura and adjacent lung tissue are usually exposed to biologically significant levels of HGF/SF. Nature Publishing Group 1996-02 /pmc/articles/PMC2074438/ /pubmed/8562345 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Eagles, G. Warn, A. Ball, R. Y. Baillie-Johnson, H. Arakaki, N. Daikuhara, Y. Warn, R. M. Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
title | Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
title_full | Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
title_fullStr | Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
title_full_unstemmed | Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
title_short | Hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
title_sort | hepatocyte growth factor/scatter factor is present in most pleural effusion fluids from cancer patients. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074438/ https://www.ncbi.nlm.nih.gov/pubmed/8562345 |
work_keys_str_mv | AT eaglesg hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients AT warna hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients AT ballry hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients AT bailliejohnsonh hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients AT arakakin hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients AT daikuharay hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients AT warnrm hepatocytegrowthfactorscatterfactorispresentinmostpleuraleffusionfluidsfromcancerpatients |